Artificial Intelligence Tools for Refining Lung Cancer Screening.

作者: J. Luis Espinoza , Le Thanh Dong

DOI: 10.3390/JCM9123860

关键词: Healthcare settingsDiseaseArtificial intelligenceScreening methodLung cancerClinical trialMedicineLung cancer screeningCancerPsychological intervention

摘要: Nearly one-quarter of all cancer deaths worldwide are due to lung cancer, making this disease the leading cause death among both men and women. The most important determinant survival in is stage at diagnosis, thus developing an effective screening method for early diagnosis has been a long-term goal care. In last decade, based on results large clinical trials, programs using low-dose computer tomography (LDCT) high-risk individuals have implemented some settings, however, various limitations, especially high false-positive rate which eventually number unnecessary diagnostic therapeutic interventions screened subjects. By complex algorithms software, artificial intelligence (AI) capable emulate human cognition analysis, interpretation, comprehension complicated data currently, it being successfully applied healthcare settings. Taking advantage ability AI quantify information from images, its superior capability recognizing patterns images compared humans, potential aid clinicians interpretation LDCT obtained setting screening. several models aimed improve detection reported. Some performed equal or even outperformed experienced radiologists distinguishing benign malign nodules those improved accuracy decreased rate. Here, we discuss recent publications utilized assess chest (CT) scans imaging obtaining

参考文章(105)
Patrick Grossmann, Olya Stringfield, Nehme El-Hachem, Marilyn M Bui, Emmanuel Rios Velazquez, Chintan Parmar, Ralph TH Leijenaar, Benjamin Haibe-Kains, Philippe Lambin, Robert J Gillies, Hugo JWL Aerts, Defining the biological basis of radiomic phenotypes in lung cancer eLife. ,vol. 6, pp. 23421- ,(2017) , 10.7554/ELIFE.23421
Rimas V. Lukas, Vinai Gondi, David O. Kamson, Priya Kumthekar, Ravi Salgia, State-of-the-art considerations in small cell lung cancer brain metastases. Oncotarget. ,vol. 8, pp. 71223- 71233 ,(2017) , 10.18632/ONCOTARGET.19333
Sean Blandin Knight, Phil A. Crosbie, Haval Balata, Jakub Chudziak, Tracy Hussell, Caroline Dive, Progress and prospects of early detection in lung cancer Open Biology. ,vol. 7, pp. 170070- ,(2017) , 10.1098/RSOB.170070
Assunta Sgambato, Francesca Casaluce, Paolo Maione, Cesare Gridelli, Targeted therapies in non-small cell lung cancer: a focus on ALK/ROS1 tyrosine kinase inhibitors. Expert Review of Anticancer Therapy. ,vol. 18, pp. 71- 80 ,(2018) , 10.1080/14737140.2018.1412260
Shu-Ju Tu, Chih-Wei Wang, Kuang-Tse Pan, Yi-Cheng Wu, Chen-Te Wu, Localized thin-section CT with radiomics feature extraction and machine learning to classify early-detected pulmonary nodules from lung cancer screening. Physics in Medicine and Biology. ,vol. 63, pp. 065005- 065005 ,(2018) , 10.1088/1361-6560/AAAFAB
Nikolaos Tsoukalas, Eleni Aravantinou-Fatorou, Panagiotis Baxevanos, Maria Tolia, Konstantinos Tsapakidis, Michail Galanopoulos, Michail Liontos, George Kyrgias, Advanced small cell lung cancer (SCLC): new challenges and new expectations Annals of Translational Medicine. ,vol. 6, pp. 145- 145 ,(2018) , 10.21037/ATM.2018.03.31
Patricia M. de Groot, Carol C. Wu, Brett W. Carter, Reginald F. Munden, The epidemiology of lung cancer. Translational lung cancer research. ,vol. 7, pp. 220- 233 ,(2018) , 10.21037/TLCR.2018.05.06
Michael Meier-Schroers, Rami Homsi, Jürgen Gieseke, Hans Heinz Schild, Daniel Thomas, Lung cancer screening with MRI: Evaluation of MRI for lung cancer screening by comparison of LDCT- and MRI-derived Lung-RADS categories in the first two screening rounds European Radiology. ,vol. 29, pp. 898- 905 ,(2019) , 10.1007/S00330-018-5607-8
Shirish M. Gadgeel, Targeted Therapy and Immune Therapy for Small Cell Lung Cancer Current Treatment Options in Oncology. ,vol. 19, pp. 53- ,(2018) , 10.1007/S11864-018-0568-3